The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth
Published Wed, 01 Feb 2012 on Long-Term Investments

Growth is a wonderful instrument for wealth building. I screened the healthcare sector by stocks with the highest earnings per share growth for the upcoming five years (at least 5 percent yearly). In addition, the company should pay today more than three percent in dividends. 10 stocks fulfilled my criteria of which six yielding above 4 percent. Nine stocks have a buy recommendation and one a strong buy rating.

GlaxoSmithKline (NYSE: GSK) has a market capitalization of $114.39 billion. The company employs 96,461 people, generates revenues of $44,734.36 million and has a net income of $2,919.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $8,615.36 million. Because of these figures, the EBITDA margin is 19.26 percent (operating margin 13.32 percent and the net profit margin finally 6.53 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $2.05. Last fiscal year, the company paid $2.05 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 22.07, Price/Sales 2.50 and Price/Book ratio 8.10. Dividend Yield: 4.95 percent. The beta ratio is 0.61.

Johnson & Johnson (NYSE: JNJ) has a market capitalization of $179.39 billion. The company employs 117,000 people, generates revenues of $65,030.00 million and has a net income of $9,672.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $12,841.00 million. Because of these figures, the EBITDA margin is 19.75 percent (operating margin 19.01 percent and the net profit margin finally 14.87 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $3.48. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 18.86, Price/Sales 2.77 and Price/Book ratio is not calculable. Dividend Yield: 3.46 percent. The beta ratio is 0.55.

Abbott Laboratories (NYSE: ABT) has a market capitalization of $84.53 billion. The company employs 90,000 people, generates revenues of $38,851.00 million and has a net income of $4,729.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $5,615.00 million. Because of these figures, the EBITDA margin is 14.45 percent (operating margin 14.45 percent and the net profit margin finally 12.17 percent).
Earnings and Dividends
Twelve trailing months earnings per share reached a value of $3.00. Last fiscal year, the company paid $1.92 in form of dividends to shareholders.
Market Valuation:
Here are the price ratios of the company: The P/E ratio is 18.06, Price/Sales 2.17 and Price/Book ratio is not calculable. Dividend Yield: 3.55 percent. The beta ratio is 0.29.

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 16.35. The dividend yield has a value of 3.71 percent. Price to book ratio is 2.77 and price to sales ratio 2.06. The operating margin amounts to 14.08 percent.... Read more